ezetimibe [orch, phsu]
mg% [qnco]
lowering [spco]
Potential [qlco]
dollar [qnco]
Savings [qnco]
Improved [qlco]
TOLERABILITY [resa]
Objective [inpr]
To [qlco]
Compare [acty]
Clinical [qlco]
Efficacy [qlco]
ezetimibe [orch, phsu]
mg% [qnco]
prescribed [hlca]
mg% [qnco]
Tablet [bodm]
Split [ftcn]
Half [qnco]
Whole [qnco]
mg% [qnco]
Tablet [bodm]
Study Design [resa]
Veterans Administration [orgt]
ezetimibe [orch, phsu]
Prescriptions [hlca]
mg% [qnco]
New [tmco]
ezetimibe [orch, phsu]
Prescriptions [hlca]
mg% [qnco]
prescribed [hlca]
mg% [qnco]
Tablet [bodm]
Split [ftcn]
Half [qnco]
Methods [inpr]
IMPACT [gngm]
ezetimibe [orch, phsu]
Dose [qnco]
strategies [menp]
Percent [qnco]
lowering [spco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Achievement [bhvr]
national [inpr]
Cholesterol [bacs, strd]
Education [edac]
program treatment [hlca]
Adult [aggp]
Panel [idcn]
III [inpr]
Goals [inpr]
Assessed [acty]
Patients [podg]
prescribed [hlca]
ezetimibe [orch, phsu]
mg% [qnco]
Result [ftcn]
Patients [podg]
prescribed [hlca]
ezetimibe [orch, phsu]
Received [qlco]
mg% [qnco]
Received [qlco]
mg% [qnco]
Patients [podg]
Evaluable [dsyn]
baseline [bodm]
post treatment [tmco]
Take [hlca]
mg% [qnco]
Dose [qnco]
Take [hlca]
mg% [qnco]
Dose [qnco]
effects [qlco]
ezetimibe [orch, phsu]
mg% [qnco]
Lipid [lipd]
Parameters [fndg]
Similar [qlco]
Reduced [qlco]
mg% [qnco]
Reduced [qlco]
Percentage [qnco]
Patients [podg]
Goal [inpr]
Similar [qlco]
mg% [qnco]
mg% [qnco]
Conclusion [idcn]
Data [idcn]
Suggest [idcn]
ezetimibe [orch, phsu]
mg% [qnco]
Equivalent [qlco]
reduction [npop]
Achievement [bhvr]
III [inpr]
Goals [inpr]
Widespread [spco]
Adoption [socb]
Low dose [qnco]
strategy [menp]
Result [ftcn]
Potential [qlco]
Cost Savings [qnco]
More [ftcn]
dollars [qnco]
Annually [tmco]
Potential [qlco]
reduction [npop]
Hepatotoxicity [inpo]
manag care [hlca]
